EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In host evolution of beta lactam resistance during active treatment for Pseudomonas aeruginosa bacteremia

Natasha Spottiswoode, Samantha Hao, Estella Sanchez-Guerrero, Angela M Detweiler, Honey Mekonen, Norma Neff, Henriette Macmillan, Brian S Schwartz, Joanne Engel, Joseph L DeRisi, Steven A Miller, Charles R Langelier

Frontiers in Cellular and Infection Microbiology · 30.08.2023 · 13

DOI: 10.3389/fcimb.2023.1241608 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 30.08.2023. Verfasst von Natasha Spottiswoode und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, University of California, San Francisco, San Francisco, CA, United States. Hauptthemen laut MEDLINE: Sepsis, Bacteremia. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, National Heart, Lung, and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multidrug-resistant (MDR) Pseudomonas aeruginosa has been declared a serious threat by the United States Centers for Disease Control and Prevention. Here, we used whole genome sequencing (WGS) to investigate recurrent P. aeruginosa bloodstream infections in a severely immunocompromised patient. The infections demonstrated unusual, progressive increases in resistance to beta lactam antibiotics in the setting of active treatment with appropriate, guideline-directed agents. WGS followed by comparative genomic analysis of isolates collected over 44 days demonstrated in host evolution of a single P. aeruginosa isolate characterized by stepwise acquisition of two de-novo genetic resistance mechanisms over the course of treatment. We found a novel deletion affecting the ampC repressor ampD and neighboring gene ampE , which associated with initial cefepime treatment failure. This was followed by acquisition of a porin nonsense mutation, OprD , associated with resistance to carbapenems. This study highlights the potential for in-host evolution of P. aeruginosa during bloodstream infections in severely immunocompromised patients despite appropriate antimicrobial therapy. In addition, it demonstrates the utility of WGS for understanding unusual resistance patterns in the clinical context.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SepsisBacteremiaUnited StatesHumansPseudomonas aeruginosabeta-Lactam ResistanceCarbapenems

Stichwörter der Autor:innen

antimicrobial resistancegram negativegram negative (G -) bacteriagram-negative bacteriahospital epidemiologywhole-genome sequencing

Substanzen

Carbapenems

Autor:innen und Institutionen

  • Division of Infectious Diseases, Department of Medicine, University of California, San Francisco, San Francisco, CA, United States.
  • Johns Hopkins School of Medicine, Baltimore, Maryland, MD, United States.
  • Chan Zuckerberg Biohub, San Francisco, CA, United States.
  • Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA, United States.
  • Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, United States.
  • Delve Bio Inc., San Francisco, CA, United States.

Förderung

  • NIAID NIH HHS
  • NHLBI NIH HHS
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Spottiswoode, N., Hao, S., Sanchez-Guerrero, E., Detweiler, A. M., Mekonen, H., Neff, N., Macmillan, H., Schwartz, B. S., Engel, J., DeRisi, J. L., Miller, S. A., & Langelier, C. R. (2023). In host evolution of beta lactam resistance during active treatment for Pseudomonas aeruginosa bacteremia. Frontiers in Cellular and Infection Microbiology, 13. https://doi.org/10.3389/fcimb.2023.1241608

Vancouver

Spottiswoode N, Hao S, Sanchez-Guerrero E, Detweiler AM, Mekonen H, Neff N, et al. In host evolution of beta lactam resistance during active treatment for Pseudomonas aeruginosa bacteremia. Frontiers in Cellular and Infection Microbiology. 2023;13. doi:10.3389/fcimb.2023.1241608

BibTeX
@article{Spottiswoode2023,
  author = {Spottiswoode, Natasha and Hao, Samantha and Sanchez-Guerrero, Estella and Detweiler, Angela M and Mekonen, Honey and Neff, Norma and Macmillan, Henriette and Schwartz, Brian S and Engel, Joanne and DeRisi, Joseph L and Miller, Steven A and Langelier, Charles R},
  title = {In host evolution of beta lactam resistance during active treatment for Pseudomonas aeruginosa bacteremia},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2023},
  volume = {13},
  doi = {10.3389/fcimb.2023.1241608}
}
Kostenlos starten →